Yael Cohen

Title: Innovations by Yael Cohen in Glioblastoma Treatment

Introduction

Yael Cohen is an accomplished inventor based in Kiryat-Ono, Israel. He has made significant contributions to the field of medical research, particularly in the treatment of glioblastoma, a highly aggressive form of brain cancer. With a total of 2 patents, Cohen's work focuses on innovative methods that aim to improve patient outcomes.

Latest Patents

Cohen's latest patents include groundbreaking methods for treating glioblastoma. One patent details compositions and methods for treating malignant glioma in a subject. This method involves administering a therapeutically effective amount of a viral vector that includes a first polynucleotide sequence encoding a Fas-chimera and a second polynucleotide sequence encoding an endothelial cell-specific promoter. Another patent focuses on the use of a specific anti-angiogenic adenoviral agent. This patent provides clinical protocols for the treatment of solid tumors using an Ad5-PPE-1-3X-fas-chimera adenovirus vector.

Career Highlights

Yael Cohen is currently associated with Vascular Biogenics Ltd., a company dedicated to developing innovative therapies for cancer treatment. His work at the company has positioned him as a key figure in the advancement of therapeutic strategies for glioblastoma.

Collaborations

Cohen collaborates with notable colleagues, including Livnat Bangio and Eyal Breitbart. These partnerships enhance the research and development efforts aimed at finding effective treatments for cancer patients.

Conclusion

Yael Cohen's innovative work in glioblastoma treatment showcases his commitment to advancing medical science. His patents reflect a deep understanding of the complexities of cancer therapy and a dedication to improving patient care.